Thursday, October 15, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 24, 2026

Red Hat AI Factory with NVIDIA Accelerates the Path to Scalable Production AI

View original at finance.yahoo.com
Red Hat AI Factory with NVIDIA Accelerates the Path to Scalable Production AI New co-engineered offering combines Red Hat AI Enterprise and NVIDIA's accelerated computing software to provide a unified foundation for building, deploying, and scaling AI-enabled applications RALEIGH, N.C., February 24, 2026--(BUSINESS WIR…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Red Hat is the open hybrid cloud technology leader, delivering a trusted, consistent and comprehensive foundation for transformative IT innovation and AI applications

    80% confidence
  • WWT is committed to helping organizations move beyond AI experimentation to successfully scale production deployments across their IT environments

    80% confidence
  • Supermicro has an extensive portfolio of Red Hat-certified systems and is dedicated to delivering the most advanced accelerated computing infrastructure for AI factories

    80% confidence
  • Enterprise AI spending expected to reach over $1 trillion by 2029, driven in large part by agentic AI applications

    80% confidence
  • Cisco is focused on helping customers move AI from experimentation to production, securely, at scale, and across distributed environments

    80% confidence
  • Enterprises are moving quickly to operationalize their AI investments, but that requires a robust, integrated infrastructure that can run reliably across their hybrid environments

    80% confidence
  • The next era of enterprise AI is about real-time action and tangible business return, requiring an industrial-strength, hybrid foundation

    80% confidence
  • The shift from AI experimentation to industrial-scale, enterprise-wide production requires a fundamental change in how we manage the AI computing stack

    80% confidence
  • Red Hat is the world's leading provider of enterprise open source software solutions

    80% confidence
  • TD SYNNEX is excited to bring the Red Hat AI Factory with NVIDIA to channel partners and their customers as a complementary addition to the TD SYNNEX Destination AI program

    80% confidence
  • Enterprises are building AI factories that turn data into intelligence at scale during inference, requiring production-grade infrastructure and software that span the hybrid cloud

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com